Zhongshan Daxue xuebao. Yixue kexue ban, 2014 摘 要: 【目的】 探讨艾塞那肽(Exenatide)在多囊卵巢综合征(PCOS)大鼠胰岛素抵抗及生殖内分泌方面的作用?【方法】 采用脱氢表雄酮(DHEA)诱导建立PCOS雌性大鼠模型?建模成功后将大鼠随机分成4组:Exenatide组(EX组,10只),二甲双胍组(MF组,10只),多囊卵巢综合征组(PCOS组,9只)及正常对照组(NC组,10只)?EX组给予Exenatide颈部皮下注射;MF组给予二甲双胍用无菌蒸馏水溶解灌胃;PCOS组和对照组每天给予正常饮食 ...
doaj
[Research progress on the roles of primary cilia in fertility]. [PDF]
Zhejiang Da Xue Xue Bao Yi Xue BanYuan Y, Liu R, Huang H.
europepmc +1 more source
[Role of hyaluronic acid synthases in female infertility-related diseases]. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue BanLiu L +5 more
europepmc +1 more source
Zhongshan Daxue xuebao. Yixue kexue ban, 1989 对76例更年期功能性子宫出血(功血)患者测定官内膜胞浆雌激素受体(ER)及孕激素受体(PR)含量,结果增殖症明显高于其它功血组。16例增殖症炔诺酮治疗前后ER、PR含量观察,有效者与无效者变化不同。提示更年期功血测定ER、PR含量可较准确反映卵巢激素对宫内膜的影响及内膜对激素的反应状态;孕激素治疗增殖症时,组织学变化与受体含量变化有关;治疗前ER、PR含量可能预测对孕激素治疗的反应。
doaj
[Application of assisted reproductive technology in fertility enhancement and preservation for women with malignant tumors]. [PDF]
Zhejiang Da Xue Xue Bao Yi Xue BanMa C +5 more
europepmc +1 more source
[Total and regional fat-to-muscle mass ratio and risk of incident benign ovarian neoplasm]. [PDF]
Beijing Da Xue Xue Bao Yi Xue BanLi H, Huang T, Wang L.
europepmc +1 more source
Zhongshan Daxue xuebao. Yixue kexue ban, 2009 【目的】 探讨顺铂(DDP)与卡铂(CBP)在卵巢癌腹腔化疗中的作用。【方法】 对我院2004年1月至2008年9月136例卵巢癌病例进行回顾性分析,按入选标准入选37例,DDP组20例,CBP组17例。【结果】 DDP组与CBP组术前及术后第1次化疗前的CA125水平比较,差异均无统计学意义(P > 0.05)。第1次化疗后,DDP组比CBP组CA125能降到更低水平(P < 0.05),但第2次、第3次或第4次化疗后两组的CA125水平比较,差异无统计学意义(P > 0.05 ...
doaj
[Fertility management in breast cancer patients: current strategies and research advances]. [PDF]
Zhejiang Da Xue Xue Bao Yi Xue BanZhou J, Jin M, Huang H.
europepmc +1 more source
[Retrospective study of fertility in female patients with hematological diseases after allogeneic hematopoietic stem cell transplantation]. [PDF]
Zhonghua Xue Ye Xue Za ZhiHuang JY +5 more
europepmc +1 more source
[Gandou Bushen decoction ameliorates ovarian injury in murine hepatolenticular degeneration via the AGE/RAGE/NF-κB signaling pathway]. [PDF]
Zhejiang Da Xue Xue Bao Yi Xue BanJiang P, Wu L, Han H.
europepmc +1 more source